under a provision that exempts tests developed and offered by a single lab from the usual
FDA review. But in a letter dated Sept. 29 and released Tuesday, the FDA determined that because the test was developed at Yale and that parts of it were manufactured elsewhere,
it must meet the agency's usual premarketing approval requirements, which could take
up to a year.
Every Day is a Blessing.